Category: Statistics

Cell Mol Biol (Noisy-le-grand). 2022 May 31;68(5):111-116. doi: 10.14715/cmb/2022.68.5.15.

ABSTRACT

Stroke is the leading cause of neurological problems and the third leading cause of death globally, leading to various neurological defects. Due to the importance of applying nursing and rehabilitation measures to reduce complications in these patients, a study was conducted to determine the effect of nursing and rehabilitation measures on the quality of life of patients with stroke. This two-stage experimental study (before and after) was performed on 20 patients with stroke admitted to the internal medicine department. Patients were selected by sampling method, which had inclusion criteria. Data were collected using a questionnaire based on the quality of life in four areas of physical, mental, general health, and social functioning before and after the intervention. Real-Time PCR measured the expression of Bcl2 / Bax genes. Descriptive and inferential statistics analyzed the data. The results showed that the mean quality of life scores in physical function, psychological, social position, and general health after nursing and rehabilitation measures increased significantly (p = .05). Also, the quality of life score after these measures had a significant increase compared to before (p = .05). Also, a significant increase was observed in the expression ratio of the Bcl2 / Bax genes in the study group compared to the control group, which indicates the effect of nursing and rehabilitation measures on cerebral ischemia. The findings showed that the application of nursing and rehabilitation measures positively affects various aspects of patients’ quality of life with stroke. These programs should be provided while educating patients and their families to help them achieve greater independence in the future.

PMID:36029508 | DOI:10.14715/cmb/2022.68.5.15

Cell Mol Biol (Noisy-le-grand). 2022 May 31;68(5):141-145. doi: 10.14715/cmb/2022.68.5.19.

ABSTRACT

Periodontal ligament fibroblasts (PDLFs) play a vital role in the period of periodontal regeneration. In addition, studies show that diphenylhydantoin (phenytoin) increases the growth of gingival fibroblasts. If this effect is also present in the periodontal ligament (PDL) fibroblasts, it may be used to regenerate periodontal tissues. Accordingly, this study aimed to compare the effect of phenytoin on the growth rate of gingival fibroblast cells and PDL in the cell culture medium. In this regard, 10 Wistar rats were selected. The gingival specimen was obtained from the area between the upper teeth, and the PDL specimen was obtained from the middle third of the lower teeth root. After transferring the samples to a suitable culture medium for culturing PDL and gingival fibroblasts, each sample was divided into two experimental and control groups. In the experimental group, 20 mg/ml phenytoin dissolved in sodium hydroxide was added to Dulbecco’s modified Eagle’s medium (DMEM). After 48 hours, fibroblast cell proliferation was assessed through a 1-WST cell proliferation kit by ELISA. The proliferation of gingival fibroblast cells and PDL in both test and control groups were statistically analyzed by the independent t-test. The results showed that the effect of phenytoin on the proliferation of gingival fibroblast cells and PDL fibroblast cells is significant. Also, the proliferation of PDL cells was significantly different from gingival cells in the experimental group (P <0.001) and was higher in PDL cells. In general, in this study, it was found that phenytoin in vitro, like in vivo, is able to increase the proliferation of gingival fibroblast cells, and this phenytoin effect is also present in PDL fibroblast cells.

PMID:36029507 | DOI:10.14715/cmb/2022.68.5.19

Cell Mol Biol (Noisy-le-grand). 2022 May 31;68(5):117-123. doi: 10.14715/cmb/2022.68.5.16.

ABSTRACT

The object of this study was to explore the correlation analysis between miRNA-21 and blood Cr levels with tumor invasion and distant metastasis in renal cancer patients. For this purpose 49 cases of renal cancer patients treated in our hospital from February 2018 to March 2020 were selected as the study group, and another 165 cases of renal benign tumors that were pathologically confirmed in our hospital during the same period were selected as the control group. MiRNA-21 and blood Cr levels, miRNA-21 and blood Cr levels at different stages, and miRNA-21 and blood Cr levels when tumor invasion and distant metastasis were present were compared between the two groups. Results showed that compared with the control group, the levels of miRNA-21 and blood Cr in the study group increased, the difference was significant (P < 0. 05); compared with stage I patients, the levels of miRNA-21 and blood Cr in stage II patients increased, compared with stage II patients, the levels of miRNA-21 and blood Cr in stage III patients increased, compared with stage III patients, the levels of miRNA-21 and blood Cr in stage IV patients increased, the difference was significant Compared with the case without tumor invasion, the levels of miRNA-21 and blood Cr in the case of tumor invasion were increased, the difference was statistically significant (P < 0. 05); compared with the case without distant metastasis, the levels of miRNA-21 and blood Cr in the case of tumor distant metastasis were increased, the difference was significant (P < 0. 05) When distant metastasis, miRNA-21 and blood Cr levels increased significantly, which showed that miRNA-21 and blood Cr levels were positively correlated with tumor invasion and distant metastasis; compared with the control group, TIMP1, TIMP2, MACC1 protein expression in the study group increased, and the three showed a positive correlation, the difference was significant (P < 0. 05). It is concluded when renal cancer patients were tested, we found that miRNA-21 and blood Cr levels were abnormally increased, and the two had a certain correlation with renal cancer tumor invasion and distant metastasis, which showed a positive correlation.

PMID:36029501 | DOI:10.14715/cmb/2022.68.5.16

Cell Mol Biol (Noisy-le-grand). 2022 May 31;68(5):54-59. doi: 10.14715/cmb/2022.68.5.7.

ABSTRACT

α-Actinin-3 is one of the key components of the Z-line structure of sarcomeres and also have importance in muscle cell signaling processes. Therefore, α-Actinin-3 gene rs1815739 polymorphism is one of the most analysed potential genetic biomarkers in sports genetic studies. We aimed to evaluate the genotypic and allelic distribution of α-Actinin-3 gene rs1815739 polymorphism in Turkish athletes. For this purpose, a total of 131 athletes (39 cyclists, 34 sprinters and distance athletes, 33 volleyball players, 15 bodybuilders and 10 ironmen) and 89 sedentary individuals were enrolled in the study. Genomic DNA from venous blood were isolated by using the PureLink DNA isolation kit by following the manufacturers’ instructions. The α-Actinin-3 rs1815739 genotyping was carried out by Real-time PCR using the commercially provided Taqman Genotyping Assay. The statistical evaluations were assessed by the chi-square testing using the GraphPad InStat statistical package. Results showed that cyclists, ironmen and volleyball players showed statistically significant differences in terms of the genotype when compared to the controls. The OR of having the dominant trait (RR genotype vs. RX+XX combined) was 0.5 (95%CI: 0.28-0.91; P= 0.02) which was statistically significant, while the OR of having the recessive trait (XX genotype vs. RR+RX combined) was 3.76 (95%CI: 1.82-7.39; P=0.0002). Our findings indicated that the α-Actinin-3 gene rs1815739 RR genotype was more prevalent in the sprinters and distance athletes. In the bodybuilders, cyclists, and ironmen it was found that they were harboring the RR and RX genotype equally. According to the results, we suggest the α-Actinin-3 rs1815739 as a potential biomarker for personal training programs.

PMID:36029499 | DOI:10.14715/cmb/2022.68.5.7

Cell Mol Biol (Noisy-le-grand). 2022 May 31;68(5):146-152. doi: 10.14715/cmb/2022.68.5.20.

ABSTRACT

Colony-stimulating factors (CSFs) are glycoproteins that stimulate the proliferation and differentiation of hematopoietic progenitor cells in the bone marrow. But numerous studies have shown that these factors can stimulate the proliferation of non-hematopoietic cells, including cancer cells. Hence, in this study, Macrophage-CSF (M-CSF), macrophage-granulocyte CSF (GM-CSF), and granulocyte-SCF (G-CSF) were evaluated in the serum of patients with breast tumors and their relationship with pathological and paraclinical parameters of the disease. In this study, 62 patients with breast cancer who had not received any treatment and 54 healthy women who matched the age group with the patient group were included as a control group. After obtaining informed consent, 5ml of peripheral blood was taken from both groups, and their serum was isolated. Serum levels of the studied cytokines were measured by the cytokine-bead array method. Data were analyzed using SPSS18 software and a significance level of 0.05. The mean serum levels of M-CSF, G-CSF, and GM-CSF growth factors in patients with breast cancer were 63.48, 16.13, and 6.11pg/ml, respectively. Although the statistical analysis did not show a significant difference between serum levels of these growth factors in the patient and control groups (p <0.05), further studies showed that with increasing disease stages from I to III, serum levels of GM-CSF significantly. Decreases (p = 0.016). Overall, the results of this study indicated the antitumor role of GM-CSF in breast cancer. However, confirmation of these results requires more complete studies with larger sample sizes.

PMID:36029494 | DOI:10.14715/cmb/2022.68.5.20

Cell Mol Biol (Noisy-le-grand). 2022 May 31;68(5):60-71.

ABSTRACT

Ghrelin is a gut hormone has stimulatory properties on food intake, fat deposition and growth hormone release. Zingerone is a component of ginger with multiple pharmacological activities. They were established that have protective roles against oxidative stress actions. We planned this study to evaluate pretreatment exogenous Ghrelin alone and or accompanied with Zingerone on ischemia-reperfusion injury to gastric fundus wall. Fifty male albino rats were used and subdivided into control, ischemic- reperfusion, Ghrelin pretreated and Ghrelin Zingerone pretreated groups. Specimens from the stomach fundus were processed for histological, immunohistochemical study and gene expression using real time PCR. Morphometric and statistical analyses were also carried out in this research. In ischemic-reperfusion sections, there were deep erosion and distortion of the mucosa. Chief cells appeared with vacuolated cytoplasm and pyknotic nuclei. Congestion of blood vessels with extravasation and cellular infiltration was also noticed. There was a decrease in mucous secreted cells in PAS-stained sections. Sections from Ghrelin pretreated and Ghrelin Zingerone pretreated groups showed a great improvement. In addition, gastric tissues with the ischemia-reperfusion group showed a significant decrease in enos and nrf2 mRNA expression while there was a significant increase in HIF and VEGF, which is counteracted to Ghrelin pretreated and Ghrelin Zingerone pretreated groups. This study revealed the vital protective role of Ghrelin in concomitant with Zingerone than pretreated Ghrelin alone on attenuating the damage changes of fundus that occurred after experimentally induced gastric ischemia-reperfusion.

PMID:36029495

Cell Mol Biol (Noisy-le-grand). 2022 May 31;68(5):103-110. doi: 10.14715/cmb/2022.68.5.14.

ABSTRACT

The study focused on the role of mitophagy in neonatal ventilator-induced lung injury (VILI). Immunoassays were used to study the TLR9 signaling pathway of neonatal VILI, expected to provide a feasible solution for neonatal VILI. The mice were randomly divided into four groups, group A: spontaneous breathing group; group B: normal tidal volume (VT) group (VT=9mL/kg); group C: high VT group (VT=39mL/kg); and group D: ODN2088 (400μg/ Only) intervention + high VT group. The four groups were compared for the expression of inflammatory factors. It was found that as the culture time increased, the expression of TLR9, MyD88, and NF-κBp65 in the lung tissue of the large VT group was significantly higher than those in the spontaneous breathing group and normal VT group, and the differences were statistically significant; and TLR9 inhibitors could activate the TLR9-MyD88 signaling pathway to up-regulate the expression of NF-κB, mediating the release of inflammatory factors to cause VILI.

PMID:36029492 | DOI:10.14715/cmb/2022.68.5.14

Cell Mol Biol (Noisy-le-grand). 2022 May 31;68(5):186-191. doi: 10.14715/cmb/2022.68.5.25.

ABSTRACT

Intra Venous Immunoglobulin (IVIG) is a plasma-derived product used to treat many autoimmune diseases, including thrombocytopenia, immunodeficiency, and infectious diseases. In this study, the effect of IVIG injection was evaluated on the number of white blood cells, neutrophils, lymphocytes, and platelets. The effect of IVIG was also considered on the percentage of CD4 and CD8 positive cells T cell lymphocytes and their absolute number in pediatric patients with immune thrombocytopenic purpura. The study was a cross-sectional study performed on 32 patients with ITP. In these patients, a blood sample was taken before and one hour after the start of the IVG injection. For all samples, a complete blood cell, platelet count, and differential blood leukocyte count were performed by Sysmex kx-21. Then labeled anti-CD4 and anti-CD8 markers were used to evaluate the type of lymphocytes. SPSS software version 15 and a t-test with a significant level of p <0.05 were used for statistical analysis of the obtained results. Pearson correlation coefficient was also used to evaluate the relationship between patients’ age and the total volume of injected IVIG results. Examination of blood cell counts showed a significant decrease in the mean of white blood cells, neutrophils, and lymphocytes after intravenous immunoglobulin injection. However, these changes were not statistically significant for platelets. A comparison of the mean percentage of CD4 and CD8 cells shows a significant increase in the CD4 / CD8 cell ratio after injection. The absolute number of CD4 and CD8 lymphocytes one hour after IVIG injection was significantly decreased, but their proportion increased after injection. Generally, IVIG reduces the absolute number of neutrophils, but this reduction is not associated with infection problems. This decrease is also seen in the number of lymphocytes. However, the change in the number and percentage of CD4 and CD8 cells depends on the sampling time following IVIG injection.

PMID:36029490 | DOI:10.14715/cmb/2022.68.5.25

Rev Med Virol. 2022 Aug 27:e2390. doi: 10.1002/rmv.2390. Online ahead of print.

ABSTRACT

With COVID-19 still hovering around and threatening the lives of many at-risk patients, an effective, quick, and inexpensive prognostic method is required. Few studies have shown fibrinogen to albumin ratio (FAR) and C-reactive protein to albumin ratio (CAR) to be promising as prognostic markers for COVID-19 disease. However, their implications remain unclear. This meta-analysis aimed to elucidate the prognostic role of FAR and CAR in COVID-19 disease. A systematic literature search was undertaken using PubMed and Embase till April 2022. Inverse variance standardised mean difference (SMD) was calculated to report the overall effect size using random effect models. The generic inverse variance random-effects method was used to pool the area under the curve (AUC) values. All statistical analyses were performed on Revman and MedCalc Software. A total of 23 studies were included. COVID-19 non-survivors had a higher CAR on admission compared with survivors (SMD = 1.79 [1.04, 2.55]; p < 0.00001; I² = 97%) and patients with a severe COVID-19 infection had a higher CAR on admission than non-severe patients (SMD = 1.21 [0.54, 1.89]; p = 0.0004; I² = 97%). Similarly, higher mean FAR values on admission were significantly associated with COVID-19 mortality (SMD = 0.55 [0.32, 0.78]; p < 0.00001; I² = 82%). However, no significant association was found between mean FAR on admission and COVID-19 severity (SMD = 0.54 [-0.09, 1.18]; p = 0.09; I² = 91%). The pooled AUC values found that CAR had a good discriminatory-power to predict COVID-19 severity (AUC = 0.81 [0.75, 0.86]; p < 0.00001; I² = 80%) and mortality (AUC = 0.81 [0.74, 0.87]; p < 0.00001; I² = 86%). FAR had a fair discriminatory-power to predict COVID-19 severity (AUC = 0.73 [0.64, 0.82]; p < 0.00001; I² = 89%). Overall, CAR was a good predictor of both severity and mortality associated with COVID-19 infection. Similarly, FAR was a satisfactory predictor of COVID-19 mortality but not severity.

PMID:36029484 | DOI:10.1002/rmv.2390

Int J Ment Health Nurs. 2022 Aug 27. doi: 10.1111/inm.13056. Online ahead of print.

ABSTRACT

Stigma attached to schizophrenia among patients is a global concern to mental health advocates. The extent of internalized stigma experienced by consumers with schizophrenia living in the community and its correlates have not been fully explored. This study aimed to examine the prevalence of high internalized stigma and its association with sociodemographic and clinical characteristics, personality traits and aspects of health-related quality of life among community-dwelling consumers with schizophrenia. A descriptive, correlational study with a cross-sectional design was conducted with 149 consumers from outpatient psychiatric clinics of two hospitals in Taiwan. Face-to-face interviews with structured questionnaires were adopted. Data were analysed with descriptive statistics, chi-squares tests, independent t-tests and a binary logistic regression analysis. Approximately 41.6% of consumers with schizophrenia experienced high internalized stigma. In the subscales, a high experience of discrimination experience (43.6%) was reported, followed by alienation (34.2%), social withdrawal (28.2%), stereotype endorsement (24.8%) and stigma resistance (20.8%). Being younger at the onset of schizophrenia, attaining lower education, having a history of suicidality, fewer positive personality traits and poor aspects of health-related quality of life were significantly associated with high internalized stigma. Personality traits in the domains of emotional stability and conscientiousness and social and environmental aspects of health-related quality of life appeared to be the most relevant to risk of high internalized stigma. Anti-stigma initiatives coupled with personality-traits modules and modifications of health-related quality of life are suggested for mental health professionals and policy makers to ameliorate internalized stigma among community-dwelling consumers with schizophrenia.

PMID:36029474 | DOI:10.1111/inm.13056